DME Capital Management’s Kyndryl KD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,816,353
Closed -$101M 48
2025
Q4
$101M Sell
3,816,353
-527,274
-12% -$14.3M 3.56% 9
2025
Q3
$130M Buy
4,343,627
+1,032,330
+31% +$35.5M 5.13% 5
2025
Q2
$139M Sell
3,311,297
-823,910
-20% -$29.8M 5.97% 5
2025
Q1
$130M Buy
4,135,207
+372,765
+10% +$14M 6.58% 4
2024
Q4
$130M Sell
3,762,442
-1,161,907
-24% -$33.8M 6.7% 4
2024
Q3
$113M Buy
4,924,349
+488,530
+11% +$11.9M 4.71% 5
2024
Q2
$117M Sell
4,435,819
-2,169,240
-33% -$52M 5.71% 5
2024
Q1
$144M Buy
+6,605,059
New +$140M 6.58% 3

Other funds holding KD

DME Capital Management's KD Position: Q1 2026 in Review

DME Capital Management sold out of Kyndryl (KD) in Q1 2026, closing a stake of 3,816,353 shares — an estimated $101M sold.

DME Capital Management first reported a position in KD in Q1 2024 and held it in 8 quarters. The position peaked at $144M in Q1 2024. 663 funds tracked by Wall St. Rank hold KD as of Q1 2026.

  • DME Capital Management reported no remaining Kyndryl position as of Q1 2026 after selling out during the quarter.
  • DME Capital Management sold 3,816,353 Kyndryl shares in Q1 2026, an estimated $101M.
  • DME Capital Management first reported a position in Kyndryl in Q1 2024 and held it in 8 quarters.
  • DME Capital Management's Kyndryl position peaked at $144M in Q1 2024.
  • 663 funds tracked by Wall St. Rank held Kyndryl as of Q1 2026.

Based on DME Capital Management's 13F filing for Q1 2026, filed 15 May 2026.